Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New personalized vaccine trains immune system to fight cancer

NCT ID NCT05741242

First seen Jan 16, 2026 · Last updated May 24, 2026 · Updated 13 times

Summary

This study tests a new type of cancer vaccine made specifically for each person. The vaccine uses pieces of the patient's own tumor to teach their immune system to attack cancer cells. It is for people with solid tumors that have not spread or have spread to other parts of the body. The goal is to see if the vaccine is safe and can help stop the cancer from growing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Anna Gattani MD PC

    New York, New York, 10028, United States

  • Mount Sinai Comprehensive Cancer Center

    Miami Beach, Florida, 33140, United States

  • Precision NextGen Oncology & Research Center

    Beverly Hills, California, 90212, United States

  • Quest Clinical Research

    San Francisco, California, 94115, United States

  • St. Louis Cancer Care

    Bridgeton, Missouri, 63044, United States

Conditions

Explore the condition pages connected to this study.